Pulmonology · Medical Literature
Multi parameter respiratory training for pulmonary rehabilitation in AECOPD a randomized controlled trial.
Abstract
Early pulmonary rehabilitation is recommended for patients with acute exacerbations of chronic obstructive pulmonary disease, yet challenges like monotony and poor adherence remain. This study evaluated a novel multi-parameter respiratory trainer against traditional methods. In a randomized controlled trial, 90 patients were assigned to three groups: multi-parameter device, three-ball trainer, or pursed-lip breathing, alongside standard medication. The primary outcomes were dyspnea, health status, and exercise capacity, with psychological status and lung function as secondary outcomes. Baseline data were comparable. Post-treatment, the multi-parameter device group demonstrated significantly greater improvements in dyspnea, CAT score, six-minute walking distance, and depression and anxiety scores compared to both traditional groups. For lung function, this group also showed superior improvement in FEV1 change versus the pursed-lip breathing group. All three groups showed significant within-group improvements. The intervention was safe, with no adverse events reported. Under supervised inpatient conditions, the multi-parameter respiratory training device is safe and effective for short-term pulmonary rehabilitation in AECOPD patients, offering superior improvements in patient-centered outcomes compared with conventional methods. However, the evidence is limited to supervised inpatient settings, and the device should be considered a complementary option to, not a replacement for, basic respiratory training when resources permit.
Clinical relevance
In hospitalized patients with acute exacerbations of COPD (AECOPD), does a novel multi-parameter respiratory training device produce superior improvements in dyspnea, health status, exercise capacity, psychological status, and lung function compared to a three-ball trainer or pursed-lip breathing, when all are added to standard medical therapy? __SNAPSHOT__ {"studyDesign":"Three-arm randomized controlled trial","setting":"Supervised inpatient setting; country not reported in abstract (likely China based on author affiliations); institution type not reported","sampleSize":"n=90 (multi-parameter device: ~30, three-ball trainer: ~30, pursed-lip breathing: ~30; exact per-group allocation not reported in abstract)","population":"Adult patients hospitalized with acute exacerbation of COPD (AECOPD); detailed inclusion/exclusion criteria, GOLD stage distribution, age, sex, and baseline lung function values not reported in abstract","intervention":"Multi-parameter respiratory training device added to standard pharmacological management","comparator":"Three-ball incentive spirometer trainer (active comparator) or pursed-lip breathing (active comparator), both added to standard pharmacological management","primaryOutcome":"Dyspnea, health status (CAT score), and exercise capacity (six-minute walk distance, 6MWD); co-primary endpoint structure","followUp":"Short-term inpatient duration; exact duration not reported in abstract","fundingSource":"Not reported"}
Key findings
All three groups demonstrated statistically significant within-group improvements across measured outcomes from baseline to post-treatment. Between-group comparisons favored the multi-parameter device group: the device group showed significantly greater improvements in dyspnea, CAT score, six-minute walk distance, and both depression and anxiety scores compared to both the three-ball trainer and pursed-lip breathing groups. For lung function, the multi-parameter device group demonstrated superior improvement in FEV1 change versus the pursed-lip breathing group; the comparison with the three-ball trainer group for FEV1 was not reported as significant in the abstract. Absolute values, between-group effect sizes, confidence intervals, p-values, NNT, and NNH are not reported in the available abstract. No adverse events occurred in any group.
Practice implications
This RCT provides short-term inpatient evidence that a multi-parameter respiratory trainer may be superior to conventional breathing rehabilitation modalities (three-ball trainer and pursed-lip breathing) for improving patient-centered outcomes—dyspnea, health status, exercise capacity, and psychological well-being—in hospitalized AECOPD patients. The FEV1 advantage was demonstrated only versus pursed-lip breathing, suggesting the device's benefit on objective lung function may be limited compared with its benefit on functional and patient-reported outcomes. Importantly, all active comparators also produced significant within-group improvements, indicating that any supervised respiratory rehabilitation during AECOPD hospitalization has value. The findings apply specifically to supervised inpatient settings and cannot be extrapolated to outpatient, home-based, or post-discharge pulmonary rehabilitation programs. Key populations inadequately represented include those with severe hypoxemia, ICU-level care, significant comorbidities, and non-Chinese settings. Clinical importance cannot be fully assessed without absolute effect sizes and minimum clinically important differences (MCIDs) for the CAT and 6MWD. NOTE: This summary is based on the published abstract only; full-text data including exact statistics, randomization methodology, blinding procedures, and attrition were not available for review. __LIMITATIONS__ Abstract-only analysis: precise effect sizes, confidence intervals, p-values, and NNT/NNH are not reported and could not be verified or calculated.,Relatively small total sample (n=90, approximately 30 per arm), limiting statistical power and precision of between-group estimates.,Short-term inpatient follow-up only: no post-discharge or long-term outcomes (e.g., readmission, mortality, exacerbation frequency) reported.,Blinding: participant blinding to intervention is inherently not feasible in behavioral/device trials of this type; assessor blinding status not reported in abstract.,Active-comparator design without a no-rehabilitation control arm limits assessment of absolute benefit over standard care alone.,Generalizability: restricted to supervised inpatient setting; applicability to outpatient, home-based, or telerehabilitation contexts is unknown.,Funding source not reported, precluding assessment of potential conflicts of interest.,COPD severity distribution (GOLD stage), exact inclusion/exclusion criteria, and attrition rates not described in abstract.,The FEV1 advantage of the multi-parameter device was significant only versus pursed-lip breathing, not reported versus three-ball trainer, raising questions about superiority across all comparators for objective lung function.,No assessment of adherence, patient acceptability, resource requirements, or cost-effectiveness of the device. __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ In hospitalized AECOPD patients, a multi-parameter respiratory training device produced significantly greater short-term improvements in dyspnea, CAT score, six-minute walk distance, and psychological outcomes compared to both a three-ball trainer and pursed-lip breathing, with no adverse events. All three active training modalities improved outcomes from baseline, reinforcing that any supervised respiratory rehabilitation during AECOPD hospitalization confers benefit. Confirmation in larger, multi-center trials with longer follow-up and full reporting of effect sizes relative to established MCIDs is needed before this device can be recommended over existing standard modalities.